Radiopharmaceuticals and Monoclonal Antibodies: Applications and Perspectives.
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F68407700%3A21340%2F16%3A00235002" target="_blank" >RIV/68407700:21340/16:00235002 - isvavai.cz</a>
Result on the web
<a href="https://www.lap-publishing.com/catalog/details/store/it/book/978-3-659-96341-4/radiopharmaceuticals?search=radiopharmaceuticals" target="_blank" >https://www.lap-publishing.com/catalog/details/store/it/book/978-3-659-96341-4/radiopharmaceuticals?search=radiopharmaceuticals</a>
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Radiopharmaceuticals and Monoclonal Antibodies: Applications and Perspectives.
Original language description
1. Introduction 2. Intact murine monoclonal antibodies and their fragments 3. Monoclonal antibodies types and their nomenclature 4. Radionuclides for monoclonal antibodies labeling 4.1. Labeling of antibodies with radiohalogens 4.2. Labeling of antibodies with radiometals 5. Special antibodies, non-antibody molecules, targeting systems and future perspectives References
Czech name
—
Czech description
—
Classification
Type
O - Miscellaneous
CEP classification
FR - Pharmacology and apothecary chemistry
OECD FORD branch
—
Result continuities
Project
<a href="/en/project/NV16-30544A" target="_blank" >NV16-30544A: New multistage nanodiagnostics for cancer imaging and prediction of antiangiogenic therapy efficacy</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2016
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů